China CFDA clears 166 innovative devices including artifical cornea

China CFDA approved 166 innovative medical devices applications in 2014, including acellular corneal stroma, the first artifical cornea product developed by Chinese firm.

In 2015, CFDA also approved devices aiming at new clinical applications, such as a particle therapy equipment for treating tumor.

CFDA also announced approval to MERS and Ebola test kits.